Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NMS Technologies is a Chinese biomedical company specializing in the development and commercialization of innovative antimicrobial solutions. Founded in 1993 and headquartered in Nanjing, the company is best known for its proprietary JUC Physical Antimicrobial Spray Dressing, a long-acting antimicrobial material that forms a positively charged film on surfaces. This technology physically attracts and neutralizes negatively charged microorganisms, including bacteria, fungi, and viruses, without the use of traditional antibiotics. JUC is widely used in clinical settings to prevent catheter-associated urinary tract infections (CAUTI), surgical site infections, and to manage complex wounds and skin conditions. The company's products are registered with the U.S. FDA, CE marked, and have a significant market presence in China and internationally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NMS Technologies.